Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncology. - Poudel YB; He L; Cox M; Zhang Q; Johnson WL; Cong Q; Cheng H; Chowdari NS; Tarby C; Donnell AF; Broekema M; O'Malley DP; et al. (ACS medicinal chemistry letters, 2024)